Dennis Riff

3.1k total citations · 1 hit paper
46 papers, 2.2k citations indexed

About

Dennis Riff is a scholar working on Surgery, Epidemiology and Anesthesiology and Pain Medicine. According to data from OpenAlex, Dennis Riff has authored 46 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Surgery, 10 papers in Epidemiology and 8 papers in Anesthesiology and Pain Medicine. Recurrent topics in Dennis Riff's work include Helicobacter pylori-related gastroenterology studies (12 papers), Inflammatory Bowel Disease (8 papers) and Anesthesia and Pain Management (6 papers). Dennis Riff is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (12 papers), Inflammatory Bowel Disease (8 papers) and Anesthesia and Pain Management (6 papers). Dennis Riff collaborates with scholars based in United States, Canada and United Kingdom. Dennis Riff's co-authors include Nelson Kinnersley, Rick A. Barbarash, Robert Bettis, Penelope Ward, Roger Mills, Frederick G. Hayden, Sudeep Singh, John J. Treanor, Daniel J. Pambianco and Howard I. Schwartz and has published in prestigious journals such as JAMA, Gastroenterology and The Journal of Infectious Diseases.

In The Last Decade

Dennis Riff

46 papers receiving 2.1k citations

Hit Papers

Efficacy and Safety of the Oral Neuraminidase Inhibitor O... 2000 2026 2008 2017 2000 250 500 750

Peers

Dennis Riff
Tilman Bauer Germany
Brent G. Petty United States
Jennifer Davidson United Kingdom
Ricardo J. José United Kingdom
Dennis C. Stokes United States
Tilman Bauer Germany
Dennis Riff
Citations per year, relative to Dennis Riff Dennis Riff (= 1×) peers Tilman Bauer

Countries citing papers authored by Dennis Riff

Since Specialization
Citations

This map shows the geographic impact of Dennis Riff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dennis Riff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dennis Riff more than expected).

Fields of papers citing papers by Dennis Riff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dennis Riff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dennis Riff. The network helps show where Dennis Riff may publish in the future.

Co-authorship network of co-authors of Dennis Riff

This figure shows the co-authorship network connecting the top 25 collaborators of Dennis Riff. A scholar is included among the top collaborators of Dennis Riff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dennis Riff. Dennis Riff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pambianco, Daniel J., Keith M. Borkett, Dennis Riff, et al.. (2015). A phase IIb study comparing the safety and efficacy of remimazolam and midazolam in patients undergoing colonoscopy. Gastrointestinal Endoscopy. 83(5). 984–992. 125 indexed citations
2.
Guenin, Eric, et al.. (2014). Pharmacokinetic Profile of Dextromethorphan Hydrobromide in a Syrup Formulation in Children and Adolescents. Clinical Drug Investigation. 34(9). 609–616. 7 indexed citations
3.
Borkett, Keith M., Dennis Riff, Howard I. Schwartz, et al.. (2014). A Phase IIa, Randomized, Double-Blind Study of Remimazolam (CNS 7056) Versus Midazolam for Sedation in Upper Gastrointestinal Endoscopy. Anesthesia & Analgesia. 120(4). 771–780. 153 indexed citations
5.
Roy, Michael J., et al.. (2013). Pharmacokinetics of Intravenous Conivaptan in Subjects With Hepatic or Renal Impairment. Clinical Pharmacokinetics. 52(5). 385–395. 6 indexed citations
6.
Richards, P., et al.. (2011). Analgesic and adverse effects of a fixed-ratio morphine-oxycodone combination (MoxDuo®) in the treatment of postoperative pain. Journal of Opioid Management. 7(3). 217–228. 29 indexed citations
7.
Langley, Joanne M., George Risi, Michael S. Caldwell, et al.. (2011). Dose-Sparing H5N1 A/Indonesia/05/2005 Pre-pandemic Influenza Vaccine in Adults and Elderly Adults: A Phase III, Placebo-Controlled, Randomized Study. The Journal of Infectious Diseases. 203(12). 1729–1738. 65 indexed citations
8.
Langley, Joanne M., Louise Frenette, Linda Ferguson, et al.. (2010). Safety and Cross‐Reactive Immunogenicity of Candidate AS03‐Adjuvanted Prepandemic H5N1 Influenza Vaccines: A Randomized Controlled Phase 1/2 Trial in Adults. The Journal of Infectious Diseases. 201(11). 1644–1653. 76 indexed citations
10.
Reinisch, Walter, László Bene, L Simón, et al.. (2009). Fontolizumab in moderate to severe Crohnʼs disease: A phase 2, randomized, double-blind, placebo-controlled, multiple-dose study. Inflammatory Bowel Diseases. 16(2). 233–242. 160 indexed citations
11.
Moberly, James B., Stuart Harris, Dennis Riff, et al.. (2007). A Randomized, Double-Blind, One-Week Study Comparing Effects of a Novel COX-2 Inhibitor and Naproxen on the Gastric Mucosa. Digestive Diseases and Sciences. 52(2). 442–450. 12 indexed citations
12.
Burakoff, Robert, Charles F. Barish, Dennis Riff, et al.. (2006). A phase 1/2A Trial of STA 5326, an oral interleukin-12/23 inhibitor, in patients with active moderate to severe Crohnʼs disease. Inflammatory Bowel Diseases. 12(7). 558–565. 82 indexed citations
13.
Pollak, Richard, Richard M. Jay, Howard J. Hillstrom, et al.. (2006). Analgesic Efficacy of Valdecoxib for Acute Postoperative Pain After Bunionectomy. Journal of the American Podiatric Medical Association. 96(5). 393–407. 24 indexed citations
14.
Scheiman, James M., Byron Cryer, Michael B. Kimmey, et al.. (2004). A randomized, controlled comparison of ibuprofen at the maximal over-the-counter dose compared with prescription-dose celecoxib on upper gastrointestinal mucosal injury. Clinical Gastroenterology and Hepatology. 2(4). 290–295. 21 indexed citations
15.
Pruitt, Ronald E., John S. Hanson, Michael Safdi, et al.. (2002). Balsalazide Is Superior to Mesalamine in the Time to Improvement of Signs and Symptoms of Acute Mild-to-Moderate Ulcerative Colitis. The American Journal of Gastroenterology. 97(12). 3078–3086. 85 indexed citations
16.
Orr, William C., M. Verlinden, Dennis Riff, et al.. (2002). Efficacy of a motilin receptor agonist (ABT‐229) for the treatment of gastro‐oesophageal reflux disease. Alimentary Pharmacology & Therapeutics. 16(4). 749–757. 13 indexed citations
18.
Talley, Nicholas J., Dennis Riff, Howard Schwartz, & Stefan P. Marcuard. (2001). Double‐blind placebo‐controlled multicentre studies of rebamipide, a gastroprotective drug, in the treatment of functional dyspepsia with or without Helicobacter pylori infection. Alimentary Pharmacology & Therapeutics. 15(10). 1603–1611. 27 indexed citations
19.
Treanor, John J., Frederick G. Hayden, Rick A. Barbarash, et al.. (2000). Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute Influenza. JAMA. 283(8). 1016–1016. 781 indexed citations breakdown →
20.
Chey, William D., Charles F. Barish, Dennis Riff, et al.. (1998). The Chemtrak Hp Chek Fingerstick Whole Blood Serology Test for the Detection of Helicobacter pylori Infection. The American Journal of Gastroenterology. 93(1). 16–19. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026